
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
Yun Chen, Boyuan Liu, Wei Yuan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105966-105966
Closed Access | Times Cited: 45
Yun Chen, Boyuan Liu, Wei Yuan, et al.
Pharmacological Research (2021) Vol. 174, pp. 105966-105966
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 188
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 188
The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Ting Ding, Chang Liu, Zhengyu Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities
Man Wang, Fei Yu, Peifeng Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Man Wang, Fei Yu, Peifeng Li
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Influence of Gut Microbiota-Mediated Immune Regulation on Response to Chemotherapy
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Yufei Deng, Xiaoying Hou, Haiping Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 604-604
Open Access | Times Cited: 9
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
Jinjing Zhang, Penghui Wang, Jiafeng Wang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107185-107185
Open Access | Times Cited: 8
Jinjing Zhang, Penghui Wang, Jiafeng Wang, et al.
Pharmacological Research (2024) Vol. 203, pp. 107185-107185
Open Access | Times Cited: 8
Butyrate inhibits the malignant biological behaviors of breast cancer cells by facilitating cuproptosis-associated gene expression
Liming Zhang, Shan Huang, Ying Yuan
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 7
Liming Zhang, Shan Huang, Ying Yuan
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 7
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Fermented natural product targeting gut microbiota regulate immunity and anti-inflammatory activity: A possible way to prevent COVID-19 in daily diet
Quancen Li, Na Li, Wenwen Cai, et al.
Journal of Functional Foods (2022) Vol. 97, pp. 105229-105229
Open Access | Times Cited: 23
Quancen Li, Na Li, Wenwen Cai, et al.
Journal of Functional Foods (2022) Vol. 97, pp. 105229-105229
Open Access | Times Cited: 23
Research progress on the impact of intratumoral microbiota on the immune microenvironment of malignant tumors and its role in immunotherapy
Jiamei Xu, Min Cheng, Jie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Jiamei Xu, Min Cheng, Jie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Yiqin Wang, Yongqiang Li, Yong Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Prognostic implications of the interaction between intratumoral microbiome and immune response in gastric cancer
S Liu, Lingyu Qi, Lu Dong, et al.
Microbiology Spectrum (2025)
Open Access
S Liu, Lingyu Qi, Lu Dong, et al.
Microbiology Spectrum (2025)
Open Access
Strategies for Remodeling the Tumor Microenvironment Using Active Ingredients of Ginseng—A Promising Approach for Cancer Therapy
Mo Li, Xin Wang, Ying Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Mo Li, Xin Wang, Ying Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
The breast tissue microbiome, stroma, immune cells and breast cancer
Tina J. Hieken, Jun Chen, Beiyun Chen, et al.
Neoplasia (2022) Vol. 27, pp. 100786-100786
Open Access | Times Cited: 21
Tina J. Hieken, Jun Chen, Beiyun Chen, et al.
Neoplasia (2022) Vol. 27, pp. 100786-100786
Open Access | Times Cited: 21
The Nutrition-Microbiota-Physical Activity Triad: An Inspiring New Concept for Health and Sports Performance
Nathalie Boisseau, Nicolas Barnich, Christelle Koechlin‐Ramonatxo
Nutrients (2022) Vol. 14, Iss. 5, pp. 924-924
Open Access | Times Cited: 19
Nathalie Boisseau, Nicolas Barnich, Christelle Koechlin‐Ramonatxo
Nutrients (2022) Vol. 14, Iss. 5, pp. 924-924
Open Access | Times Cited: 19
The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions
Yu Fu, Jia Li, Wenyun Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1560-1591
Open Access | Times Cited: 12
Yu Fu, Jia Li, Wenyun Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 4, pp. 1560-1591
Open Access | Times Cited: 12
Intestinal Microbiota Modulates the Antitumor Effect of Oncolytic Virus Vaccines in Colorectal Cancer
Xia Chen, Guanjun Wang, Ling Qin, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 4, pp. 1228-1241
Closed Access | Times Cited: 4
Xia Chen, Guanjun Wang, Ling Qin, et al.
Digestive Diseases and Sciences (2024) Vol. 69, Iss. 4, pp. 1228-1241
Closed Access | Times Cited: 4
Influence of the gut microbiota on immune cell interactions and cancer treatment
Chunxiao Liu, Lingfeng Fu, Yuxin Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Chunxiao Liu, Lingfeng Fu, Yuxin Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma
Tengfei Li, Xun Li, Pengcheng Kang, et al.
Translational Oncology (2025) Vol. 53, pp. 102283-102283
Open Access
Tengfei Li, Xun Li, Pengcheng Kang, et al.
Translational Oncology (2025) Vol. 53, pp. 102283-102283
Open Access
The interplay between gut bacteria and targeted therapies: implications for future cancer treatments
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Gut microbiota in melanoma: effects and pathogeneses
Wenwen Liu, Xin Yang, Yuwei Zhou, et al.
Microbiological Research (2025), pp. 128144-128144
Closed Access
Wenwen Liu, Xin Yang, Yuwei Zhou, et al.
Microbiological Research (2025), pp. 128144-128144
Closed Access
Intratumoral microbiota: new frontiers in tumor immunity
Zhilin Zhang, Yiqun Liao, Dong Tang
Carcinogenesis (2022) Vol. 43, Iss. 8, pp. 719-727
Closed Access | Times Cited: 16
Zhilin Zhang, Yiqun Liao, Dong Tang
Carcinogenesis (2022) Vol. 43, Iss. 8, pp. 719-727
Closed Access | Times Cited: 16
Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma
Daniel John, Rishabh Yalamarty, Armon Barakchi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3148-3148
Open Access | Times Cited: 10
Daniel John, Rishabh Yalamarty, Armon Barakchi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3148-3148
Open Access | Times Cited: 10